Press Release: Pila Pharma AB announces outcome in the rights issue

Press Release: THE ONGOING RIGHTS ISSUE IN PILA PHARMA HAS ENTERED ITS LAST SUBSCRIPTION WEEK AND WILL END MONDAY 4 DECEMBER. THE LAST DAY OF TRADING SUBSCRIPTION RIGHTS IS WEDNESDAY 29 NOVEMBER

Press Release: PILA PHARMA WILL PRESENT AT "STORA AKTIEDAGARNA" IN STOCKHOLM TOMORROW, 27 NOVEMBER 2023 AT 8:00 CET

Press Release: PILA PHARMA ANNOUNCES PRECLINICAL RESEARCH COLLABORATION

Press Release: PILA PHARMA PUBLISHES INFORMATION MEMORANDUM

Note: PILA PHARMA INVITES TO AFTER-WORK INVESTOR MEETINGS

Report: PILA PHARMA PUBLISHES INTERIM REPORT (1 July - 30 September 2023)

Press Release: PILA PHARMA'S BOARD OF DIRECTORS HAS RESOLVED TO CARRY OUT A RIGHTS ISSUE OF SHARES OF APPROXIMATELY SEK 26.2 MILLION

Press Release: CORRECTION: Clarification and extended information on previous press release regarding convertible loans and their structure.

Press Release: PILA PHARMA announces capital infusion via convertible loans

Report: PILA PHARMA publishes interim report (1 April - 30 June 2023)

Press Release: Pila Pharma ändrar språk för informationsgivning till engelska